PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1299737
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1299737
3D bioprinting market size was valued at USD 2,352.9 Million in 2022, expanding at a CAGR of 20.1% from 2023 to 2030.
A 3D bioprinting used biomaterials technology and its laser printer U-FAB to create a pulmonary epithelial model. Moreover, the respiratory system is lined up with tissue known as the respiratory epithelial. In addition, this epithelial helps as a defense against various diseases. Furthermore, the primary application of 3D bioprinting is regenerative medicine includes methods to regrow, replace, and repair damaged & diseased organs, tissues, and cells.
In 3D bioprinting, technological advancements enable the production of liver modeling, epidermal layer growth bones, cancer treatments, and tissue production. Additionally, with the field advancement, 3D bioprinters used for clinical testing and drug screening slightly reduce the need for animal testing. This in turn projected to drive the market demand for the 3D bioprinting market. However, a lack of skilled professionals in the 3D bioprinters industry may hamper the market growth over the forecast period.
Moreover, 3d bioprinting has applications in the manufacturing of materials, regenerative medicine, and biocompatible cells which assist to address the requirement for tissues and organs suitable for organ transplantation. This is anticipated to propel the market growth. The COVID-19 pandemic affected the global 3D bioprinting market globally. The market is experiencing huge demand owing to various pharmaceutical and biopharmaceutical companies stepping up to support doctors, researchers, and medical professionals in every manner.
The global 3d bioprinting market is segmented on the basis of components, technology, material, application, and region.
The market is divided into two categories based on components: 3D bioprinters and bioinks. The 3D bioprinters sector is likely to maintain its dominance. A scale-up procedure and quicker manufacturing procedure are required for 3D bioprinting on a commercial level.
The market is divided into four categories based on technology: magnetic levitation, inkjet-based, syringe-based, laser-based, and others. The inkjet-based sector is expected to hold the largest market share. The global requirement for inkjet-based printing in the healthcare sector is a major factor that propels the segment's growth.
The market is divided into two categories based on material: research applications and clinical applications. The clinical applications sector is expected to dominate the market. The massive use of medical pills to treat chronic disease is stimulating segment growth.
The market is divided into three categories based on application: research organizations & academic institutes, biopharmaceutical companies, and hospitals. The biopharmaceutical companies sector is likely to possess the market. The increasing demand for biopharmaceuticals and the use of bio-drugs efficiently in this technology will likely drive the market demand for this segment.
The increasing geriatric population and rising incidence of dental conditions are such factors surging the demand for the 3D printing market. Additionally, key players are increasing R&D investment, rapid technological advancements, and growing consumer awareness are witnessed in the sales of 3D printers. Market players are also focusing on collaboration, new product launches, mergers & acquisitions, and partnerships to gain a foothold in the market globally. For instance, in March 2022, CELLINK, A BICO Company launched the BIO CELLX, a first of its kind biodispensing platform to automate 3D Cell Culture.
This proposed research study on 3D bioprinting market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for 3D bioprinting market.
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the 3D bioprinting market.
Impact of COVID-19 on 3D bioprinting market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on 3D bioprinting market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the 3D bioprinting market, we have also included competitive landscape and key innovator analysis for the 3D bioprinting market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the 3D bioprinting market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global 3D bioprinting market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.
The scope of this report covers the market by its major segments, which include as follows: